Fail Early in Clinical Development if You Want to Succeed
Contributor:
Andrea Charles
Posted: 06/11/2010 12:00:00 AM EDT | 1
Posted: 06/11/2010 12:00:00 AM EDT | 1
|
If you are going to fail, it is better to fail earlier. All phases of clinical research are striving to reduce attrition, streamline their processes and develop drugs cost-effectively. Identification of which drugs are likely to fail at an early stage is paramount for product success across the innovation chain.
Speaking to Pharma IQ ...
-
7 Unique Challenges Facing the US Generic Pharma Industry -
Getting eCTD Submissions Right -
eCTD Continues Rise to Global Prominence -
Making Drug Formation Crystal Clear -
Growing Need for Pharmacogenomics -
3 Essential Tips for Finding the Right CMO: From a Specialist Pharma Perspective -
PDCO and Industry Working on a New Relationship -
How Do We Ensure Best Practice in the Clinical Supply Chain? -
Pharmaceutical Firms Make Immunogenicity a Priority -
Embracing Pharmacovigilance with Technology in Biopharmaceuticals
* = required.
Not a member yet? Sign up
You Should Check Out:
|
|
How do you outline your clinical development plan?
|
Events of Interest
-
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem
April 4, 2013
Register Now -
Site Quality Management and Risk-Based Monitoring: A New Approach
December 4, 2012
Register Now -
Use of Cardiac Safety Data in Early Phase Trials to Supplement or Replace a Thorough QT Trial
June 11, 2012
Register Now -
Electronic Laboratory Notebooks Online
December 2, 2011
Register Now




Replies (0)
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!